Anti-Inflammatory characteristics of local anesthetics: inhibition of TNF-α secretion of lipopolysaccharide-stimulated leucocytes in human blood samples

Background. Local anesthetics (LAs) have potent anti-inflammatory properties. Inflammatory down-regulation is crucial in diseases with overactive immune reactions, such as acute respiratory distress syndrome (ARDS) and chronic inflammation. We investigated the influence of four LAs, procaine, lidoca...

Full description

Saved in:
Bibliographic Details
Main Authors: Weinschenk, Stefan (Author) , Weiss, Carsten (Author) , Benrath, Justus (Author) , Baehr, Volker von (Author) , Strowitzki, Thomas (Author) , Feißt, Manuel (Author)
Format: Article (Journal)
Language:English
Published: 18 March 2022
In: International journal of molecular sciences
Year: 2022, Volume: 23, Issue: 6, Pages: 1-14
ISSN:1422-0067
DOI:10.3390/ijms23063283
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/ijms23063283
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1422-0067/23/6/3283
Get full text
Author Notes:Stefan Weinschenk, Carsten Weiss, Justus Benrath, Volker von Baehr, Thomas Strowitzki and Manuel Feißt
Description
Summary:Background. Local anesthetics (LAs) have potent anti-inflammatory properties. Inflammatory down-regulation is crucial in diseases with overactive immune reactions, such as acute respiratory distress syndrome (ARDS) and chronic inflammation. We investigated the influence of four LAs, procaine, lidocaine, mepivacaine, and bupivacaine, on the reduction of tumor necrosis factor-alpha (TNF-α) secretion in lipopolysaccharide (LPS)-activated human leucocytes. Methods. Blood samples of 28 individuals were stimulated with LPS. The reduction of TNF-α production by each of the four LAs added (0.5 mg/mL) was measured and correlated with biometric variables. A response was defined as reduction to <85% of initial levels. Results. All four LAs down-regulated the TNF-α secretion in 44-61%: Bupivacaine (44.4%), lidocaine (61.5%), mepivacaine (44.4%), and procaine (50% of the individuals, “responders”). The TNF-α secretion was reduced to 67.4, 68.0, 63.6, and 67.1% of the initial values in responders. The effects in both patients and healthy persons were the same. Interindividual responses to LAs were not correlated with the duration or type of complaints, basal TNF-α serum level, sex, BMI, or age of responders. Conclusions. Four clinically relevant LAs (amid-LA and ester-LA) attenuate the inflammatory response provoked by LPS. They are potential candidates for drug repositioning in treating overactive immune reactions and chronic inflammation.
Item Description:Gesehen am 04.06.2022
Physical Description:Online Resource
ISSN:1422-0067
DOI:10.3390/ijms23063283